Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains

International Journal of Antimicrobial Agents

Volumn 31, Issue 1, 2008, Pages 83-85

  Thomson, Kenneth S ^a   Black, Jennifer ^a   Moland, Ellen Smith ^a   Reuben, Jay ^b   Wiles, Tim ^b   Brasso, William ^b  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; ENZYME SYNTHESIS; ESCHERICHIA COLI; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN;

EID: 36849036397     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.08.015     Document Type: Letter

References (7)

1. Sanders C.C., Iaconis J.P., Bodey G.P., and Samonis G. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 32 (1988) 1365-1369
2. Brenner D.G., and Knowles J.R. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli. Biochemistry 23 (1984) 5839-5846
3. Bush K., Macalintal C., Rasmussen B.A., Lee V.J., and Yang Y. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob Agents Chemother 37 (1993) 851-858
4. Thomson K.S., and Moland E.S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 45 (2001) 3548-3554
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. M100-S15. Wayne, PA: CLSI; 2005.
6. Sanders C.C., Sanders Jr. W.E., Thomson K.S., and Iaconis J.P. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases. J Antimicrob Chemother 24 Suppl. A (1989) 187-196
7. Sanders C.C., Sanders Jr. W.E., Goering R.V., and McCloskey R.V. Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillin. Antimicrob Agents Chemother 31 (1987) 1164-1168